Evotec Share Price

Evotec Share Price

NASDAQ: EVO | Others
$1.48
+$0.03 (2.07%) Last updated on 18 Nov, 2026 | 21:18 IST
  • Performance
  • Chart
  • Fundamentals
  • Profit & Loss
  • Balance Sheet
  • Cash Flow
  • Corporate Actions
  • About
  • Price history
  • FAQs

Evotec Stock Performance

Open
N/A
Prev. Close
$1.45
Circuit Range
N/A
Day Range
N/A
Year Range
$1.33 - $3.84
Volume
N/A
Average Traded
N/A

Evotec Share Price Chart

Line chart of the Evotec price trend over the selected period. The price rose overall, ranging from 1.48 to 1.49, ending at 1.48.
$0.00$0.00
L
Show Current Price
H

Evotec Stock Fundamentals & Key Indicators

Market Cap
N/A
PE Ratio (TTM)
N/A
Dividend Yield
N/A
EPS (TTM)
N/A
Revenue (TTM)
$924.97B
Return On Equity (TTM)
N/A
Profit Margin
-13.13%
Debt to Equity
N/A
Quarterly Earnings Growth YoY
N/A

Evotec Annual Profit & Loss

All figures in USD

Particulars2022202320242025
Revenue$806.06$863.83$829.30$924.97
Net Profit-$188.42-$92.76-$204.03-$121.45
Net Profit Margin-23.38%-10.74%-24.60%-13.13%
Income ChangeN/A50.77%-119.95%40.47%

Evotec Balance Sheet

All figures in USD Million

Particulars2025202420232022
Non Current Assets1115.781280.461491.61269.59
Current Assets895.14709.63998.411151.7
Total Assets2010.921990.082490.02421.29
Non Current Liabilities624.37640.36738.43785.58
Current Liabilities431.85358.56513.57362.25
Total Liabilities1056.22998.921252.01147.83
Shareholders' Equity954.69991.161238.011273.46

Evotec Cash Flow

Annually

All figures in USD Million

Particulars2025202420232022
Operating-10.7718.9640.28220.77
Investing201.32-74.07-14.69-442.8
Financing-44.15-167.9779.55-62.37

Corporate Actions

Dividend
Ex-date: 11 Jan 2019

Dividend
Ex-date: 12 Dec 2018

Dividend
Ex-date: 08 Nov 2018

Dividend
Ex-date: 10 Oct 2018

Dividend
Ex-date: 13 Sep 2018

Dividend
Ex-date: 10 Aug 2018

Dividend
Ex-date: 11 Jul 2018

Dividend
Ex-date: 08 Jun 2018

About Evotec

Evotec SE is a life science company focused on developing pharmaceutical products through standalone services, integrated R&D programs, and strategic partnerships with pharmaceutical and biotechnology companies, academic institutions, and other partners. It operates across drug discovery, preclinical development, and manufacturing, with expertise in areas including oncology, central nervous system, cardiovascular-renal, immune and inflammatory, infectious, and other diseases. The Company generates revenue through fee-for-service and FTE-based services, milestones, and royalties, and equity ownership in biotechnology and academic projects. It operates through the Shared R&D and Discovery & Preclinical Development (D&PD) segments, with the majority of revenue generated from the USA.

Evotec Historical Returns

Share price history by day, with open and close prices and the day's change
MonthOpenCloseChange %
Nov 2026
$1.53
$1.45
-4.61%
Oct 2026
$1.65
$1.52
-11.11%
Sep 2026
$1.81
$1.71
-12.31%
Aug 2026
$1.96
$1.95
+1.04%
Jul 2026
$2.89
$1.93
-31.07%
Jun 2026
$3.07
$2.80
-8.79%
May 2026
$3.11
$3.07
-0.97%
Apr 2026
$2.57
$3.10
+24.50%
Mar 2026
$3.30
$2.49
-26.98%
Feb 2026
$3.53
$3.41
-6.83%
Jan 2026
$3.20
$3.66
+16.56%
Dec 2025
$3.21
$3.14
-4.99%

Evotec Share Price FAQs